PPPatricia Priest

Patricia Priest

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Patricia Priest has a total of 156 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ethnic equity in Aotearoa New Zealand's COVID-19 response: A descriptive epidemiological study

    by S. Jefferies, C. Gilkison, P. Duff, C. Grey, N. French, H. Carr, P. Priest, S. Crengle


  • Open Access

    Zoonotic transmission of asymptomatic carriage Staphylococcus aureus on dairy farms in Canterbury, New Zealand

    by Christina Straub, William Taylor, Nigel P. French, David R. Murdoch, Patricia Priest, Trevor Anderson, Pippa Scott

    Zoonotic pathogen transmission is of growing concern globally, with agricultural intensification facilitating interactions between humans, livestock and wild animals. Staphylococcus aureus is a major human pathogen, but it also causes mastitis in dairy cattle, leading to an economic burden on the dairy industry. Here, we investigated transmission within and between cattle and humans, including potential zoonotic transmission of S. aureus isolated from cattle and humans from three dairy farms and an associated primary school in New Zealand. Nasal swabs (N=170) were taken from healthy humans. Inguinal and combined nasal/inguinal swabs were taken from healthy cattle (N=1163). Whole-genome sequencing was performed for 96 S. aureus isolates (44 human and 52 cattle). Multilocus sequence typing and assessments of antimicrobial resistance and virulence were carried out. Potential within- and across-species transmission events were determined based on single nucleotide polymorphisms (SNPs). Thirteen potential transmission clusters were detected, with 12 clusters restricted to within-species and one potential zoonotic transmission cluster (ST5). Potential transmission among cattle was mostly limited to single age groups, likely because different age groups are managed separately on farms. While the prevalence of antimicrobial resistance (AMR) was low among both bovine and human isolates, the discovery of an extended-spectrum beta-lactamase gene (bla TEM-116) in a bovine isolate was concerning. This study provides evidence around frequency and patterns of potential transmission of S. aureus on dairy farms and highlights the AMR and virulence profile of asymptomatic carriage S. aureus isolates.


  • Open Access

    Sensitivity of Reverse Transcription Polymerase Chain Reaction Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Through Time

    by Rachelle N Binny, Patricia Priest, Nigel P French, Matthew Parry, Audrey Lustig, Shaun C Hendy, Oliver J Maclaren, Kannan M Ridings, Nicholas Steyn, Giorgia Vattiato, et al.

    Background: Reverse transcription polymerase chain reaction (RT-PCR) tests are the gold standard for detecting recent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Reverse transcription PCR sensitivity varies over the course of an individual’s infection, related to changes in viral load. Differences in testing methods, and individual-level variables such as age, may also affect sensitivity.Methods: Using data from New Zealand, we estimate the time-varying sensitivity of SARS-CoV-2 RT-PCR under varying temporal, biological, and demographic factors.Results: Sensitivity peaks 4–5 days postinfection at 92.7% (91.4%–94.0%) and remains over 88% between 5 and 14 days postinfection. After the peak, sensitivity declined more rapidly in vaccinated cases compared with unvaccinated, females compared with males, those aged under 40 compared with over 40s, and Pacific peoples compared with other ethnicities.Conclusions: Reverse transcription PCR remains a sensitive technique and has been an effective tool in New Zealand’s border and postborder measures to control coronavirus disease 2019. Our results inform model parameters and decisions concerning routine testing frequency.


  • CHAPTER 11. New Zealand's Response to the First Wave of COVID-19

    by Sarah Jefferies, Anne French, Petra Muellner, Virginia Hope, Nigel French, Caroline McElnay, Patricia Priest

    New Zealand's initial public health response to the coronavirus disease 2019 (COVID-19) pandemic was characterised by risk-informed early border closures, a relatively rapid implementation of national lockdown including severe movement restrictions, healthcare reprioritisation, enhancements in contact tracing, isolation and testing capacities. The initial response was facilitated with effective community engagement. This led to a low relative burden of COVID-19 in New Zealand, including only 22 deaths, and limited inequitable COVID-19 outcomes during the first wave of community transmission of disease. New Zealand's initial goal of disease elimination was reached by May 2020; however, the broader costs of this approach including socio-economic impacts, and longer-term sustainability, remain to be fully discerned.

  • Open Access

    Predicting the impact of household contact and mass chemoprophylaxis on future new leprosy cases in South Tarawa, Kiribati: A modelling study

    by Charlotte Gilkison, Stephen Chambers, David J Blok, Jan Hendrik Richardus, Eretii Timeon, Erei Rimon, Patricia Priest

    The country of Kiribati is a small Pacific island nation which had a new case detection rate of 191 per 100,000 in 2016, and is one of the few countries yet to reach the WHO leprosy elimination goal. Chemoprophylaxis of household contacts of new cases, or to the whole population in a highly endemic areas have been found to be effective in reducing new case rates. This study investigated the potential impact of different chemoprophylaxis strategies on future cases in South Tarawa, the main population centre of Kiribati. The microsimulation model SIMCOLEP was calibrated to simulate the South Tarawa population and past leprosy control activities, and replicate annual new cases from 1989 to 2016. The impact of six different strategies for delivering one round of single dose rifampicin (SDR) chemoprophylaxis to household contacts of new cases and/or one or three rounds of SDR to the whole population was modelled from 2017 to 2030. Our model predicted that continuing the existing control program of high levels of public awareness, passive case detection, and treatment with multidrug treatment would lead to a substantial reduction in cases but this was less effective than all modelled intervention scenarios. Mass chemoprophylaxis led to a faster initial decline in cases than household contact chemoprophylaxis alone, however the decline under the latter was sustained for longer. The greatest cumulative impact was for household contact chemoprophylaxis with three rounds of mass chemoprophylaxis at one-year intervals. The results suggest that control of leprosy would be achieved most rapidly with a combination of intensive population-based and household chemoprophylaxis. These findings may be generalisable to other countries where crowding places social contacts as well as household contacts of cases at risk of developing leprosy. Leprosy rates in Kiribati are some of the highest in the world and it is one of the few countries yet to reach the World Health Organization leprosy elimination goal of a prevalence of less than one case per 10,000 population. The greatest burden is in the capital South Tarawa and the connected islet of Betio. Interest has increased for the use of chemoprophylaxis, the administration of preventive antibiotics to apparently healthy individuals who may be incubating the disease, which has been demonstrated to be effective in both household contacts and the whole population in two recent studies. In this study we used the individual-based model SIMCOLEP to predict the impact of six difference scenarios using single dose rifampicin (SDR) chemoprophylaxis in household contacts and/or the entire population on future new cases in South Tarawa. We found that all chemoprophylaxis strategies were predicted to be more effective than the current control strategy, particularly a combination of household contact chemoprophylaxis alongside three rounds given to the entire population in consecutive years.


  • Open Access

    Risk Factors for Legionella longbeachae Legionnaires’ Disease, New Zealand

    by Emma Kenagy, Patricia C. Priest, Claire M. Cameron, Debbie Smith, Pippa Scott, Vicki Cho, Peter Mitchell, David R. Murdoch

    Legionella longbeachae, found in soil and compost-derived products, is a globally underdiagnosed cause of Legionnaires’ disease. We conducted a case–control study of L. longbeachae Legionnaires’ disease in Canterbury, New Zealand. Case-patients were persons hospitalized with L. longbeachae pneumonia, and controls were persons randomly sampled from the electoral roll for the area served by the participating hospital. Among 31 cases and 172 controls, risk factors for Legionnaires’ disease were chronic obstructive pulmonary disease, history of smoking >10 years, and exposure to compost or potting mix. Gardening behaviors associated with L. longbeachae disease included having unwashed hands near the face after exposure to or tipping and troweling compost or potting mix. Mask or glove use was not protective among persons exposed to compost-derived products. Precautions against inhaling compost and attention to hand hygiene might effectively prevent L. longbeachae disease. Long-term smokers and those with chronic obstructive pulmonary disease should be particularly careful.


    • 17 February 2017
      • Vol. 130  (1450) , 94-101

    Proposed new industry code on unhealthy food marketing to children and young people: will it make a difference?

    by Boyd Swinburn, Stefanie Vandevijvere, Alistair Woodward, Andrew Hornblow, Ann Richardson, Barbara Burlingame, Barry Borman, Barry Taylor, Bernhard Breier, Bruce Arroll, et al.

    Reducing the exposure of children and young people to the marketing of unhealthy foods is a core strategy for reducing the high overweight and obesity prevalence in this population. The Advertising Standards Authority (ASA) has recently reviewed its self-regulatory codes and proposed a revised single code on advertising to children. This article evaluates the proposed code against eight criteria for an effective code, which were included in a submission to the ASA review process from over 70 New Zealand health professors. The evaluation found that the proposed code largely represents no change or uncertain change from the existing codes, and cannot be expected to provide substantial protection for children and young people from the marketing of unhealthy foods. Government regulations will be needed to achieve this important outcome.


  • Open Access

    A One Health future to meet the AMR challenge?

    by Patricia Priest, Leah Toombs-Ruane, Jackie Benschop, Sara Burgess, Nigel French, David Murdoch


  • Eficacia de la detección sistemática de la gripe en las fronteras en los viajeros que llegan por vía aérea

    by Patricia C. Priest, Lance C. Jennings, Alasdair R. Duncan, Cheryl R. Brunton, Michael G. Baker

    Objetivos. Se midieron los síntomas y la prevalencia de la gripe (también llamada influenza), así como la eficacia del mecanismo de detección sistemática basado en los síntomas y la temperatura para diagnosticar la gripe en viajeros internacionales que llegaban por vía aérea. Métodos. El presente estudio transversal recopiló datos de viajeros que llegaron al aeropuerto internacional de Christchurch (Nueva Zelandia) en el invierno del 2008 mediante un cuestionario de salud, medición de la temperatura y toma de muestras de las vías respiratorias. Resultados. De los viajeros, 15 976 (68%) entregaron los formularios completos. De ellos, 17% notificaron al menos un síntoma de gripe; los síntomas más comunes fueron rinorrea o congestión nasal (10%) y tos (8%). Se tomaron muestras de las vías respiratorias de 3 769 viajeros. La prevalencia estimada de la gripe fue de 1,1% (4% en las personas sintomáticas, 0,2% en las asintomáticas). La sensibilidad de los criterios de detección varió de 84% para “cualquier síntoma” a 3% para la fiebre de 37,8 °C o mayor. El valor predictivo positivo fue bajo para todos los criterios. Conclusiones. El método de detección sistemática en las fronteras mediante la autonotificación de síntomas y la toma de la temperatura presenta limitaciones para impedir que una gripe pandémica entre en un país. Basarse en criterios como “cualquier síntoma” o la tos haría que se investigara a varias personas no infectadas, mientras que algunas personas infectadas pasarían inadvertidas. Si se usaran criterios más específicos como la fiebre, la mayoría de las personas infectadas entrarían en el país a pesar del mecanismo de detección.

  • Effectiveness of Border Screening for Detecting Influenza in Arriving Airline Travelers

    by Patricia C. Priest, Lance C. Jennings, Alasdair R. Duncan, Cheryl R. Brunton, Michael G. Baker

    Objectives. We measured symptom and influenza prevalence, and the effectiveness of symptom and temperature screening for identifying influenza, in arriving international airline travelers. Methods. This cross-sectional study collected data from travelers to Christchurch International Airport, New Zealand, in winter 2008, via a health questionnaire, temperature testing, and respiratory sampling. Results. Forms were returned by 15 976 (68%) travelers. Of these, 17% reported at least 1 influenza symptom, with runny or blocked nose (10%) and cough (8%) most common. Respiratory specimens were obtained from 3769 travelers. Estimated prevalence of influenza was 1.1% (4% among symptomatic, 0.2% among asymptomatic). The sensitivity of screening criteria ranged from 84% for “any symptom” to 3% for a fever of 37.8 °C or greater. The positive predictive value was low for all criteria. Conclusions. Border screening using self-reported symptoms and temperature testing has limitations for preventing pandemic influenza from entering a country. Using “any symptom” or cough would lead to many uninfected people being investigated, yet some infected people would remain undetected. If more specific criteria such as fever were used, most infected people would enter the country despite screening.